#None #Veeva Systems #Commercial Pulse #HCP Data

Transforming Healthcare Professional Engagement with Veeva Commercial Pulse

Veeva Systems, a frontrunner in providing cloud solutions for the life sciences industry, has introduced an innovative product: Veeva Commercial Pulse. This new data subscription service significantly enhances how pharmaceutical companies can segment and target healthcare professionals (HCPs) through unparalleled data access and multichannel engagement metrics. Available immediately, Pulse aims to streamline commercial operations, allowing organizations to extract valuable insights to optimize their outreach strategies.

Key Features of Veeva Commercial Pulse

Veeva Commercial Pulse stands out as a game-changer for businesses engaged in the life sciences sector. The platform offers:

• - Comprehensive HCP Access Data: Leveraging over 500 million interactions recorded through Veeva's Customer Relationship Management (CRM) solutions, Pulse provides the most complete and up-to-date HCP access data available today.
• - True Industry Census: Through a robust global dataset, companies can tap into metrics covering access and engagement across more than three million HCPs, spanning 102 specialties and encompassing 21 countries.
• - Data Aggregation for Privacy Protection: To ensure compliance with stringent data privacy regulations, the HCP metrics are carefully segmented and aggregated by factors such as country and specialty, allowing organizations to act while safeguarding individual privacy.

Peter Stark, Veeva's executive vice president of Data Cloud, praises the potential impact of Pulse: “This is a breakthrough data product that will greatly improve segmentation and targeting around the globe. We look forward to collaborating with our early adopters to realize the value Pulse data brings to their commercial operations.”

Global Availability and Future Expansion

As of now, Veeva Commercial Pulse launches with data covering key markets such as the United States, Canada, Germany, the United Kingdom, and many others, totaling 21 stipulated countries. Additional releases that will encompass data from further countries in Asia and Europe are anticipated next year, illustrating Veeva’s commitment to expanding its global footprint.

This quarterly data product will empower commercial operations and data analytics teams to make informed decisions, improving outreach strategies and ultimately leading to enhanced engagement with healthcare professionals.

The first set of data for the year 2024 will be available starting this April, establishing a regular rhythm of data updates to ensure users have access to the latest insights necessary for crafting effective marketing strategies.

About Veeva Systems

Veeva Systems holds a prestigious position as a leader in the life sciences cloud software arena, dedicated to fostering innovation and ensuring the success of its clients. Serving more than a thousand customers, ranging from established biopharmaceutical giants to emerging biotech firms, Veeva focuses on striking a balance between the interests of its stakeholders—customers, employees, shareholders, and the industry as a whole. As a Public Benefit Corporation, Veeva emphasizes responsible corporate practices and community engagement, reflecting its values and commitments.

In conclusion, Veeva Commercial Pulse is set to redefine how life sciences companies approach healthcare professional engagement, driving better-targeted marketing and improved outcomes. As Veeva continues to innovate and enhance its offerings, it remains at the forefront of transforming healthcare interactions with data-driven solutions. Companies eager to accelerate their engagement strategies should explore the insights available through Veeva Commercial Pulse and begin their journey towards improved operational excellence and better healthcare outreach.

For more information regarding Veeva Commercial Pulse, visit veeva.com/eu/Pulse.